CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sichuan Zitonggong Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sichuan Zitonggong Pharmaceutical Co Ltd
#456 Anji Street Neijiang Economy &
Technology Development District
Phone: +86 8322382628p:+86 8322382628 NEIJIANG, SIC  641000  China Ticker: 832566832566
Business Summary
Sichuan Zitonggong Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, manufacturing, and sales of medicines. The Company offers a range of medicines under brand Zitonggong, and its products include citicoline sodium tablets, rizatriptan monobenzoate capsules, Dongfang Weiyao Jiaonang, and Xuanju Jiaonang, among others. The Company also manufactures calculus bovis factitius, rizatriptan benzoate, and other drug substances. The Company mainly conducts businesses within the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

General Information
Number of Employees: 321 (As of 12/31/2023)
Outstanding Shares: 143,561,080 (As of 3/31/2024)
Shareholders: 8,659
Stock Exchange: BJS
Fax Number: +86 8322190956


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024